Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Engel, Peter
IMPAHCT, NCT05036135 / 2021-001910-13: A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)	Terminated	2/3	202	Europe, Canada, US, RoW	AV-101, Placebo	Aerovate Therapeutics, Aerovate Therapeutics, Inc.	Pulmonary Arterial Hypertension	08/24	08/24
ASPIRE PH, NCT04555161: Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System	Recruiting	N/A	30	US	Aria CV Pulmonary Hypertension System, Aria CV PH System	Aria CV, Inc	Pulmonary Arterial Hypertension, Pulmonary Hypertension, Right Heart Dysfunction	10/25	10/26
Lawrence, Christine R
No trials found
Garza, Deborah
No trials found